Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4997 Neoplasms 4192 Prostatic Neoplasms 2426 Carcinoma, Non-Small-Cell Lung 2261 Colorectal Neoplasms 2050 Lung Neoplasms 1703 Multiple Myeloma 1454 Lymphoma 1403 Leukemia, Myeloid, Acute 1379 Neoplasm Metastasis 1372 Melanoma 1269 Pancreatic Neoplasms 1200 Leukemia 1194 Ovarian Neoplasms 1190 Lymphoma, Non-Hodgkin 1128 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1088 Head and Neck Neoplasms 1055 Leukemia, Lymphocytic, Chronic, B-Cell 994 Lymphoma, Follicular 896 Colonic Neoplasms 893 Brain Neoplasms 875 Stomach Neoplasms 854 Recurrence 848 Carcinoma, Hepatocellular 845 Glioblastoma 837 Lymphoma, Large B-Cell, Diffuse 770 Rectal Neoplasms 758 Uterine Cervical Neoplasms 725 Carcinoma, Renal Cell 704 Hodgkin Disease 696

Interventions

NVP-BKM120 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × Pre-menopausal Breast Cancer × Clear all

NCT02058381 2020-03-09

B-YOND

Novartis

Phase 1 Completed

Pre-menopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡